Scynexis (SCYX) Liabilities from Discontinued Operations (2014 - 2015)
Scynexis' (SCYX) quarterly Liabilities from Discontinued Operations came in at 2099000.0 in Q2 2015, down 13.26% on a QoQ basis from 2420000.0 in Q4 2014.
Scynexis (SCYX) Liabilities from Discontinued Operations (2014 - 2015) Analysis & Trends
Scynexis (SCYX) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 2099000.0 in Q2 2015.
- Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 2099000.0 in Q2 2015, while the trailing twelve-month figure through Jun 2015 was 2099000.0 (changed N/A YoY) and the FY2014 annual result came in at 2420000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations declined to 2099000.0 in Q2 2015, from 2420000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 2420000.0 in Q4 2014 to a low of 2099000.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 2.10 Mn |
| Jun 30, 2015 | 2.10 Mn |
| Dec 31, 2014 | 2.42 Mn |
| Dec 31, 2014 | 2.42 Mn |